Ovation Science

Ovation Science ROA

The Return on Assets (ROA) of Ovation Science (OVAT.CN) as of Oct 28, 2026 is -762.22 %. In the previous year, Return on Assets (ROA) was -713.95 % — a change of 6.76% (lower).

ROA

-762.22 %

YoY

6.76%

Last updated:

In 2025, Ovation Science's return on assets (ROA) was -762.22 %, a 6.76% increase from the -713.95 % ROA in the previous year.

The Ovation Science ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2018
-18.66 CAD
Jan 1, 2019
-45.44 CAD
Jan 1, 2020
-36.44 CAD
Jan 1, 2021
-310.92 CAD
Jan 1, 2022
-757.06 CAD
Jan 1, 2023
-1,057.58 CAD
Jan 1, 2024
-713.95 CAD
Jan 1, 2025
-762.22 CAD
The Ovation Science ROA history
YEARROAYoY
-762.22 %+6.76%
-713.95 %-32.49%
-1,057.58 %+39.69%
-757.06 %+143.49%
-310.92 %+753.29%
-36.44 %-19.80%
-45.44 %+143.56%
-18.66 %+13.59%
-16.42 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ovation Science Stock analysis

What does Ovation Science do? Ovation Science, Inc. generates revenue through the development and sale of topical and transdermal skin products utilizing its patented Invisicare delivery technology. The company offers products under the Ovation brand, ARLO CBD Beauty, and InVibe MD, featuring formulations with hemp seed oil, CBD, THC, and cannabinoid derivatives. These products are distributed through direct sales and licensing agreements, targeting consumers seeking science-based skincare and wellness solutions. The firm leverages its Invisicare technology to create creams and lotions that deliver cannabinoids and hemp seed oil effectively for topical and transdermal use. The company's product portfolio includes ARLO CBD Beauty for skincare and InVibe MD for wellness, both powered by the Invisicare delivery system. Ovation Science licenses its technology and products to third parties while also selling directly under its own brands. The primary market segments are consumers interested in cannabinoid-based skincare and wellness products, with a focus on the efficacy and science-backed nature of their formulations. All products are manufactured and distributed under the company's brand labels, emphasizing the patented delivery system as a key differentiator. Ovation Science, Inc. monetizes its patented Invisicare technology by developing and distributing products containing cannabinoids, hemp seed oil, and synthetic cannabis derivatives. The company's revenue streams come from both direct sales of Ovation-branded products and licensing agreements for its technology and formulations. The firm's focus on topical and transdermal delivery ensures that its products are positioned within the growing market for cannabinoid-infused skincare and wellness solutions, targeting customers who prioritize the science and technology behind their skincare products. Ovation Science is one of the most popular companies on Eulerpool.

ROA Details

Understanding Ovation Science's Return on Assets (ROA)

Ovation Science's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Ovation Science's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Ovation Science's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Ovation Science’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Ovation Science stock

Return on Assets (ROA) of Ovation Science is -762.22 % in 2025.

Return on Assets (ROA) of Ovation Science changed from -713.95 % to -762.22 %, representing a 6.76% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Ovation Science since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Ovation Science with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Ovation Science

All Key Metrics — Ovation Science